KWF
Long-Term Programme Biomarkers 2025
Full proposal deadline was 1 April 2025 (12:00 noon); funding decision expected July 2025. Call appears closed.
Last verified:
Details
| Funder | KWF |
| Budget | €1M–€4M |
| Duration | 3-5 years |
| Consortium | Required — 4+ participating parties |
| Application | 2-stage: pre-proposal (closed 3 Dec 2024) → full proposal (closed 1 Apr 2025); interviews 27 May 2025 |
| TRL | 7 |
| Eligible countries | NL |
Eligibility & scope
Translates clinical-grade oncology biomarkers (TRL 7) to nationwide implementation. Open to any tumour type with a clear clinical need. Requires a research consortium of 4+ parties; for-profit partners (>250 FTE) must contribute 10% co-financing. An HTA expert must be part of the project team. Eligibility checklist must be submitted before pre-proposal. PhD positions strongly discouraged due to fail-fast termination risk.
Related on Grantsby
- KWF writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
More from KWF
Proof Of Concept 2026-2
Deadline: 2 Jun 2026KWF Proof of Concept (PoC) Programme – Call 2026-PoC-2
Deadline: 2 Jun 2026Up to €150,000 incl. VATKWF Proof of Concept 2026-PoC-2
Deadline: 2 Jun 2026Up to €150,000 incl. VATINTER-LOCAL: International Call for Better Local Treatment of Rare/Hard-to-Treat Cancers
Deadline: 18 Jun 2026International consortium funding (5 European charities)INTER-LOCAL: International Funding Call for Local Treatment Strategies in Rare and Hard-to-Treat Cancers
Deadline: 18 Jun 2026
Does this grant match your research?
Sign up free to get a personalised match score and weekly alerts for grants like this.
Get started free